MedPath

CogEcig: Cognitive Functioning and Electronic Cigarette

Not Applicable
Completed
Conditions
Tobacco Abuse Smoke
Interventions
Other: one high 2,4% nicotine
Other: Own Brand cigarette
Other: original 7,4 mg nicotine
Other: nicotine free
Other: Ego 9mg
Registration Number
NCT01735487
Lead Sponsor
Universita degli Studi di Catania
Brief Summary

The aim of the present study is to compare cognitive scores (attention, executive function and working memory) of different e-Cigarette strength with usual cigarettes.

Detailed Description

The study is randomised cross-over trial designed to compare: 1) Cognitive performances levels for four different e-Cigarette strength. Participants will be requested to abstain from smoking and alcohol from 20:00 on the night before each study day and from food and caffeine for at least 1 h before the session. On arrival at the study centre, carbon monoxide (CO) will be measured in participants' expired breath. If CO will be \>15 parts per million (ppm), the assigned study treatment will be allocated; however, if CO was \>15 ppm or they will report smoking in the previous 12 h, participants will be rescheduled wherever possible to a subsequent session.

On the first study day, participants will be randomised to use one of five ordered conditions: Electronic Nicotine Delivery Device (ENDD) (fourth generation) containing nicotine 2,4%; Electronic Nicotine Delivery Device (ENDD (second generation) containing nicotine 7,4 mg; Electronic Nicotine Delivery Device (ENDD containing nicotine 9 mg; Electronic Nicotine Delivery Device (ENDD nicotine free; their usual cigarette. Additionally participants will be trained to use an electronic cigarette. The following tests will be completed at the each visits: Continuous Performance Test - AX version (CPT-AX), Wisconsin card sorting test( WCST), Working memory test (N-BACK).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • 20 regular smokers (smoking ≥ 15 factory-made cigarettes per day for at least the past 10 years and not currently attempting to quit smoking or wishing to do so in the next 30 days, CO > 10 parts per million ) will be recruited from the local Hospital staff in Catania, Italy.
Exclusion Criteria
  • people who reported recent myocardial infarction, angina pectoris or other serious medical conditions (diabetes mellitus, severe allergies, poorly controlled asthma or other airways disease, poorly controlled psychiatric disorders or current chemical dependence other than nicotine) and
  • pregnancy,
  • breastfeeding,
  • blood pressure > 180 mm Hg systolic and/or 100 mm Hg diastolic,
  • weight < 45 or > 120 kg, or
  • current use of any other smoking cessation medications

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Own Brand cigaretteone high 2,4% nicotineSmoke Own Brand cigarette, 15 puff of cigarette.
Own Brand cigaretteoriginal 7,4 mg nicotineSmoke Own Brand cigarette, 15 puff of cigarette.
Own Brand cigarettenicotine freeSmoke Own Brand cigarette, 15 puff of cigarette.
Own Brand cigaretteEgo 9mgSmoke Own Brand cigarette, 15 puff of cigarette.
One High 2,4% nicotineOwn Brand cigaretteSmoke electronic cigarette One High 2,4% nicotine for a day, 15 puff of e-cigarette.
One High 2,4% nicotineoriginal 7,4 mg nicotineSmoke electronic cigarette One High 2,4% nicotine for a day, 15 puff of e-cigarette.
One High 2,4% nicotinenicotine freeSmoke electronic cigarette One High 2,4% nicotine for a day, 15 puff of e-cigarette.
One High 2,4% nicotineEgo 9mgSmoke electronic cigarette One High 2,4% nicotine for a day, 15 puff of e-cigarette.
Original 7,4 mg nicotineOwn Brand cigaretteSmoke electronic cigarette Original 7,4 mg nicotine for a day. 15 puff of e-cigarette.
Original 7,4 mg nicotineone high 2,4% nicotineSmoke electronic cigarette Original 7,4 mg nicotine for a day. 15 puff of e-cigarette.
Original 7,4 mg nicotinenicotine freeSmoke electronic cigarette Original 7,4 mg nicotine for a day. 15 puff of e-cigarette.
Nicotine FreeOwn Brand cigaretteSmoke electronic cigarette nicotine free (15 puff)
Nicotine Freeone high 2,4% nicotineSmoke electronic cigarette nicotine free (15 puff)
Nicotine Freeoriginal 7,4 mg nicotineSmoke electronic cigarette nicotine free (15 puff)
Nicotine FreeEgo 9mgSmoke electronic cigarette nicotine free (15 puff)
EGO 9mgOwn Brand cigaretteSmoke electronic cigarette EGO for a day (15 puff)
EGO 9mgone high 2,4% nicotineSmoke electronic cigarette EGO for a day (15 puff)
EGO 9mgoriginal 7,4 mg nicotineSmoke electronic cigarette EGO for a day (15 puff)
EGO 9mgnicotine freeSmoke electronic cigarette EGO for a day (15 puff)
Primary Outcome Measures
NameTimeMethod
Cognitive Performances35 minutes

Compare cognitive performances in subjects who smoke "Categoria" electronic cigarettes labelled Original 7,4 mg nicotine , "Categoria" electronic cigarettes labelled One 2,4% nicotine, "Categoria" electronic cigarettes labelled "Mint" nicotine free, electronic cigarettes labelled Ego 9 mg nicotine with usual cigarettes.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centro per la Prevenzione e Cura del Tabagimso

🇮🇹

Catania, Italy

© Copyright 2025. All Rights Reserved by MedPath